NCT03357627
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03357627
Title A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | DEU | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
Emory University Atlanta Georgia 30322 United States Details
NorthShore Medical Group - Evanston Evanston Illinois 60201 United States Details
Ingalls Memorial Hospital Harvey Illinois 60426 United States Details
Norton Cancer Institute - Shelbyville Shelbyville Kentucky 40065 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Baylor Scott & White Research Institute Dallas Texas 75246 United States Details
Hopital Maisonneuve-Rosemont Montreal Quebec H1T 2M4 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Universitatsklinikum Heidelberg Heidelberg Baden-Wurttemberg 69120 Germany Details
Universitatsklinikum Ulm Ulm Baden-Wurttemberg 89081 Germany Details
Universitatklinikum der Ludwig-Maximilians-Universitat Munchen München Bavaria 81377 Germany Details
Universitatsklinikum Frankfurt Frankfurt am Main Hesse 60590 Germany Details
Universitatsmedizin der Johannes Gutenberg Universitat Mainz Rhineland-Palatinate 55131 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field